GRI BIO, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
GRI BIO, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • GRI BIO, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $14.5M, a 315% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $14.5M +$11M +315% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $3.5M -$3.51M -50.1% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $7.01M +$2.86M +69.1% Dec 31, 2021 10-K 2023-02-24
Q4 2020 $4.15M Dec 31, 2020 10-K 2022-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.